# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-213399
Filing Date
2026-05-08
Accepted
2026-05-08 08:11:39
Documents
75
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | alxo-20260331.htm iXBRL | 10-Q | 2621571
2 | EX-10.1 | alxo-ex10_1.htm | EX-10.1 | 58656
3 | EX-31.1 | alxo-ex31_1.htm | EX-31.1 | 19638
4 | EX-31.2 | alxo-ex31_2.htm | EX-31.2 | 19870
5 | EX-32.1 | alxo-ex32_1.htm | EX-32.1 | 11685
6 | EX-32.2 | alxo-ex32_2.htm | EX-32.2 | 11709
| Complete submission text file | 0001193125-26-213399.txt |  | 9871031

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | alxo-20260331.xsd | EX-101.SCH | 1172535
79 | EXTRACTED XBRL INSTANCE DOCUMENT | alxo-20260331_htm.xml | XML | 1774125

Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

EIN.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39386 | Film No.: 26956167
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)